NCT03037385
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03037385
Title Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (ARROW)
Acronym ARROW
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Blueprint Medicines Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | DEU | BEL

Facility Status City State Zip Country Details
Mayo Clinic Hospital Phoenix Arizona 85054 United States Details
UC Irvine Medical Center Orange California 92868 United States Details
University of Colorado Anschutz Medical Campus Aurora Colorado 80045 United States Details
Georgetown University Medical Center Washington D.C. District of Columbia 20007 United States Details
Mayo Clinic-Jacksonville Jacksonville Florida 32224 United States Details
Sylvester Comprehensive Cancer Center Miami Florida 33136-1002 United States Details
Maryland Oncology Hematology, P.A. Columbia Maryland 21044-3257 United States Details
Massachusetts General Hospital. Boston Massachusetts 02114-2696 United States Details
University of Michigan Ann Arbor Michigan 48109-0934 United States Details
Mayo Clinic Rochester Rochester Minnesota 55902-3003 United States Details
Washington University School of Medicine in St. Louis St Louis Missouri 63110-1010 United States Details
Albany Medical Center Albany New York 12208-3412 United States Details
Weill Cornell Medical College-New York Presbyterian Hospital New York New York 10021 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Texas Oncology-Austin Midtown Austin Texas 78705-1165 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030-4000 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Antwerp University Hospital Edegem 2650 Belgium Details
Beijing Cancer Hospital Beijing 100036 China Details
Beijing Cancer Hospital Beijing 100142 China Details
The affiliated Cancer Hospital, School of Medicine, UESTC Chengdu 610041 China Details
West China Hospital, Sichuan University Chengdu 610041 China Details
Chongqing Cancer Hospital Chongqing 400030 China Details
Fujian Provincial Cancer Hospital Fuzhou 350014 China Details
First Affiliated Hospital of Gannan Medical University Ganzhou 341000 China Details
Sun Yet-sen University Cancer Center Guangzhou 510060 China Details
Guangdong General Hospital Guangzhou 510080 China Details
Zhejiang Cancer Hospital Hangzhou 310022 China Details
Jinan Central Hospital Jinan 250013 China Details
Gansu Cancer Hospital Lanzhou 730050 China Details
Fudan University Shanghai Cancer Center Shanghai 200032 China Details
Fudan University Shanghai Cancer Center Shanghai 200120 China Details
Tianjin Medical University Cancer Institute & Hospital Tianjing 300060 China Details
Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430023 China Details
Henan Cancer Hospital Zhengzhou 450008 China Details
Institut Bergonie Bordeaux 33000 France Details
Centre Hospitalier Régional Universitaire de Lille (CHRU) - Hôpital Claude Huriez Lille 59037 France Details
Centre Léon Bérard Lyon 69008 France Details
Centre Antoine Lacassagne Nice 6100 France Details
Institut Curie Paris 75248 France Details
CHU de Rennes - Hopital de Pontchaillo Rennes 35033 France Details
Hôpital Larrey Toulouse 31059 France Details
Gustave Roussy Villejuif 94800 France Details
Helios Klinikum Emil von Behring GmbH Berlin 14165 Germany Details
Universitätsklinikum Essen Essen 45122 Germany Details
Thoraxklinik Heidelberg gGmbH Heidelberg 69126 Germany Details
Klinikum der Universität München München 81377 Germany Details
Pius-Hospital Oldenburg 26121 Germany Details
The Chinese University of Hong Kong Shatin 123456 Hong Kong Details
Ospedale Santa Maria Delle Croci Ravenna Emilia-Romagna 48100 Italy Details
Istituto Nazionale Tumori Regina Elena Rome Lazio 00144 Italy Details
IEO Milan Lombardy 20141 Italy Details
Asst Grande Ospedale Metropolitano Niguarda Milan Lombardy 20162 Italy Details
Antoni van Leeuwenhoek Ziekenhuis Amsterdam 1066 CX Netherlands Details
Universitair Medisch Centrum Groningen Groningen 9713 GZ Netherlands Details
National Cancer Centre Singapore 169610 Singapore Details
Seoul National University Hospital Seoul 03080 South Korea Details
Asan Medical Center Seoul 05505 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
Severance Hospital, Yonsei University Health System Seoul 120-752 South Korea Details
Institut Catala d Oncologia Hospitalet L'Hospitalet de Llobregat Barcelona 08908 Spain Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Hospital Clinic de Barcelona Barcelona 08036 Spain Details
Hospital Ramon y Cajal Madrid 28034 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
National Taiwan University Hospital Taipei 10002 Taiwan Details
Taipei Veterans General Hospital Taipei 11217 Taiwan Details
Guys and St Thomas NHS Foundation Trust, Guys Hospital London SE1 9RT United Kingdom Details
University College London Hospitals NHS Foundation Trust London W1T 7HA United Kingdom Details
The Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field